Biosimilars for Management of Crohn Disease.

Nielsen, Ole Haagen; Ainsworth, Mark Andrew

Nielsen, Ole Haagen; Ainsworth, Mark Andrew.

Affiliation

Nielsen OH; University of Copenhagen Herlev Hospital, Herlev, Denmark (O.H.N.).
Ainsworth MA; Odense University Hospital, Odense, Denmark (M.A.A.).

Ann Intern Med ; 170(2): 129-130, 2019 01 15.

Article in En | MEDLINE | ID: mdl-30535358

Subject(s)

Biosimilar Pharmaceuticals/economics; Biosimilar Pharmaceuticals/therapeutic use; Cost Savings; Crohn Disease/drug therapy; Drug Development/economics; European Union; Humans; Infliximab/therapeutic use; Prescription Fees; Tumor Necrosis Factor-alpha/antagonists & inhibitors; United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crohn Disease / Cost Savings / Biosimilar Pharmaceuticals Type of study: Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Ann Intern Med Year: 2019 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google